HIV-positive demonstrate more salt sensitivity and nocturnal non-dipping blood pressure than HIV-negative individuals.

Hypertension Nocturnal blood pressure dipping Salt Salt sensitivity

Journal

Clinical hypertension
ISSN: 2056-5909
Titre abrégé: Clin Hypertens
Pays: England
ID NLM: 101669508

Informations de publication

Date de publication:
15 Jan 2021
Historique:
received: 19 05 2020
accepted: 14 12 2020
entrez: 15 1 2021
pubmed: 16 1 2021
medline: 16 1 2021
Statut: epublish

Résumé

High dietary salt and a lack of reduced blood pressure (BP) at night (non-dipping) are risk factors for the development of hypertension which may result in end-organ damage and death. The effect of high dietary salt on BP in black people of sub-Saharan Africa living with HIV is not well established. The goal of this study was to explore the associations between salt sensitivity and nocturnal blood pressure dipping according to HIV and hypertension status in a cohort of adult Zambian population. We conducted an interventional study among 43 HIV-positive and 42 HIV-negative adults matched for age and sex. Study participants were instructed to consume a low (4 g) dietary salt intake for a week followed by high (9 g) dietary salt intake for a week. Salt resistance and salt sensitivity were defined by a mean arterial pressure difference of ≤5 mmHg and ≥ 8 mmHg, respectively, between the last day of low and high dietary salt intervention. Nocturnal dipping was defined as a 10-15% decrease in night-time blood pressure measured with an ambulatory blood pressure monitor. The median age was 40 years for both the HIV-positive and the HIV-negative group with 1:1 male to female ratio. HIV positive individuals with hypertension exhibited a higher BP sensitivity to salt (95%) and non-dipping BP (86%) prevalence compared with the HIV negative hypertensive (71 and 67%), HIV positive (10 and 24%) and HIV-negative normotensive (29 and 52%) groups, respectively (p < 0.05). Salt sensitivity was associated with non-dipping BP and hypertension in both the HIV-positive and HIV-negative groups even after adjustment in multivariate logistic regression (< 0.001). The results of the present study suggest that high dietary salt intake raises blood pressure and worsens nocturnal BP dipping to a greater extent in hypertensive than normotensive individuals and that hypertensive individuals have higher dietary salt intake than their normotensive counterparts. Regarding HIV status, BP of HIV-positive hypertensive patients may be more sensitive to salt intake and demonstrate more non-dipping pattern compared to HIV-negative hypertensive group. However, further studies with a larger sample size are required to validate this.

Sections du résumé

BACKGROUND BACKGROUND
High dietary salt and a lack of reduced blood pressure (BP) at night (non-dipping) are risk factors for the development of hypertension which may result in end-organ damage and death. The effect of high dietary salt on BP in black people of sub-Saharan Africa living with HIV is not well established. The goal of this study was to explore the associations between salt sensitivity and nocturnal blood pressure dipping according to HIV and hypertension status in a cohort of adult Zambian population.
METHODS METHODS
We conducted an interventional study among 43 HIV-positive and 42 HIV-negative adults matched for age and sex. Study participants were instructed to consume a low (4 g) dietary salt intake for a week followed by high (9 g) dietary salt intake for a week. Salt resistance and salt sensitivity were defined by a mean arterial pressure difference of ≤5 mmHg and ≥ 8 mmHg, respectively, between the last day of low and high dietary salt intervention. Nocturnal dipping was defined as a 10-15% decrease in night-time blood pressure measured with an ambulatory blood pressure monitor.
RESULTS RESULTS
The median age was 40 years for both the HIV-positive and the HIV-negative group with 1:1 male to female ratio. HIV positive individuals with hypertension exhibited a higher BP sensitivity to salt (95%) and non-dipping BP (86%) prevalence compared with the HIV negative hypertensive (71 and 67%), HIV positive (10 and 24%) and HIV-negative normotensive (29 and 52%) groups, respectively (p < 0.05). Salt sensitivity was associated with non-dipping BP and hypertension in both the HIV-positive and HIV-negative groups even after adjustment in multivariate logistic regression (< 0.001).
CONCLUSIONS CONCLUSIONS
The results of the present study suggest that high dietary salt intake raises blood pressure and worsens nocturnal BP dipping to a greater extent in hypertensive than normotensive individuals and that hypertensive individuals have higher dietary salt intake than their normotensive counterparts. Regarding HIV status, BP of HIV-positive hypertensive patients may be more sensitive to salt intake and demonstrate more non-dipping pattern compared to HIV-negative hypertensive group. However, further studies with a larger sample size are required to validate this.

Identifiants

pubmed: 33446278
doi: 10.1186/s40885-020-00160-0
pii: 10.1186/s40885-020-00160-0
pmc: PMC7809779
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2

Subventions

Organisme : FIC NIH HHS
ID : D43 TW009744
Pays : United States
Organisme : FIC NIH HHS
ID : D43 TW009337
Pays : United States

Références

Hypertension. 2016 Sep;68(3):e7-e46
pubmed: 27443572
Lancet. 2019 May 11;393(10184):1958-1972
pubmed: 30954305
Curr Hypertens Rep. 2014 Aug;16(8):465
pubmed: 24924995
Curr Hypertens Rev. 2015;11(1):30-7
pubmed: 26028240
AIDS Res Hum Retroviruses. 2017 Feb;33(2):181-186
pubmed: 27527002
BMJ Open. 2017 Jul 9;7(7):e016602
pubmed: 28694350
Cardiovasc J Afr. 2014 Jul-Aug;25(4):153-7
pubmed: 25192297
Curr Hypertens Rev. 2015;11(1):14-21
pubmed: 26028243
J Am Soc Hypertens. 2013 Mar-Apr;7(2):170-9
pubmed: 23428408
Nat Rev Nephrol. 2019 May;15(5):290-300
pubmed: 30804523
BMC Res Notes. 2019 Jul 16;12(1):424
pubmed: 31311574
Adv Exp Med Biol. 2017;956:61-84
pubmed: 27757935
Am J Physiol Regul Integr Comp Physiol. 2017 Dec 1;313(6):R706-R710
pubmed: 28931546
Am J Physiol Renal Physiol. 2015 Feb 1;308(3):F167-78
pubmed: 25377913
Curr Hypertens Rep. 2019 Jun 4;21(7):56
pubmed: 31165257
PLoS One. 2016 Feb 16;11(2):e0148920
pubmed: 26882469
PLoS One. 2017 Sep 20;12(9):e0185003
pubmed: 28931072
J Hypertens. 2009 Jan;27(1):48-54
pubmed: 19145767
J Am Heart Assoc. 2020 Feb 18;9(4):e011450
pubmed: 32064996
J Hum Hypertens. 2002 Apr;16(4):255-60
pubmed: 11967719
Pediatr Nephrol. 2021 Feb;36(2):237-243
pubmed: 31897716
Hypertension. 2001 Feb;37(2 Pt 2):429-32
pubmed: 11230313
Med Clin North Am. 2009 May;93(3):733-51
pubmed: 19427502
Hypertension. 2016 Jul;68(1):123-32
pubmed: 27217403
Am J Clin Nutr. 2010 Jul;92(1):77-82
pubmed: 20444953
Hypertension. 2018 Jun;71(6):1269-1324
pubmed: 29133354
Hypertension. 2006 Oct;48(4):527-33
pubmed: 16940213
Curr Hypertens Rep. 2013 Apr;15(2):108-13
pubmed: 23397215
Indian Heart J. 2018 Jul - Aug;70(4):556-564
pubmed: 30170653
Public Health Genomics. 2017;20(1):9-26
pubmed: 28482349
Circulation. 2012 Dec 11;126(24):2880-9
pubmed: 23124030

Auteurs

Sepiso K Masenga (SK)

School of Medicine and Health Sciences, HAND Research Group, Mulungushi University, Livingstone, Zambia. smasenga@mu.ac.zm.
School of Health Sciences, Department of Biomedical Sciences, University of Zambia, Lusaka, Zambia. smasenga@mu.ac.zm.

Annet Kirabo (A)

Vanderbilt Institute for Global Health and Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Benson M Hamooya (BM)

School of Medicine and Health Sciences, HAND Research Group, Mulungushi University, Livingstone, Zambia.
School of Public Health, University of Zambia, Lusaka, Zambia.

Selestine Nzala (S)

School of Medicine, University of Zambia, Lusaka, Zambia.

Geoffrey Kwenda (G)

School of Health Sciences, Department of Biomedical Sciences, University of Zambia, Lusaka, Zambia.

Douglas C Heimburger (DC)

Vanderbilt Institute for Global Health and Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
School of Medicine, University of Zambia, Lusaka, Zambia.

Wilbroad Mutale (W)

School of Public Health, University of Zambia, Lusaka, Zambia.

John R Koethe (JR)

Vanderbilt Institute for Global Health and Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Leta Pilic (L)

Faculty of Sport, Health and Applied Science, St. Mary's University, Twickenham, London, UK.

Sody M Munsaka (SM)

School of Health Sciences, Department of Biomedical Sciences, University of Zambia, Lusaka, Zambia.

Classifications MeSH